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Abstract
Studies based on cell-free systems and on in vitro–cultured living cells support the concept that many cellular processes,
such as transcription initiation, are highly dynamic: individual proteins stochastically bind to their substrates and
disassemble after reaction completion. This dynamic nature allows quick adaptation of transcription to changing conditions.
However, it is unknown to what extent this dynamic transcription organization holds for postmitotic cells embedded in
mammalian tissue. To allow analysis of transcription initiation dynamics directly into living mammalian tissues, we created a
knock-in mouse model expressing fluorescently tagged TFIIH. Surprisingly and in contrast to what has been observed in
cultured and proliferating cells, postmitotic murine cells embedded in their tissue exhibit a strong and long-lasting
transcription-dependent immobilization of TFIIH. This immobilization is both differentiation driven and development
dependent. Furthermore, although very statically bound, TFIIH can be remobilized to respond to new transcriptional needs.
This divergent spatiotemporal transcriptional organization in different cells of the soma revisits the generally accepted
highly dynamic concept of the kinetic framework of transcription and shows how basic processes, such as transcription, can
be organized in a fundamentally different fashion in intact organisms as previously deduced from in vitro studies.
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Introduction
Basal transcription/repair factor IIH (TFIIH) is a ten-subunit
complex [1], essential for both RNA polymerase I and II (RNAP1
and 2) transcription initiation and nucleotide excision repair
(NER) [2]. NER is an important DNA repair process, which is
able to remove a broad spectrum of different DNA lesions.
Inherited defects in NER cause severe cancer predisposition and/
or premature aging, illustrating its biological significance [3]. In
RNAP2 transcription and DNA repair, TFIIH acts as a DNA
helix opener, required for transition of initiation to early
elongation of RNAP2 and establishment of the preincision NER
complex [4,5]. Mutations in this complex are associated with a
surprising phenotypic heterogeneity, ranging from the (skin)
cancer-prone disorder xeroderma pigmentosum (XP) to the severe
progeroid conditions Cockayne syndrome (CS) and trichothiodis-
trophy (TTD), the latter additionally characterized by brittle hair
and nails [1,6–8]. Since TFIIH is considered to be a general or
basal transcription factor and essential NER component, it is
surprising to note that TFIIH-associated syndromes present
different pathologically affected tissues. For instance, within
TTD, primarily differentiated cells appear to be affected. TTD-
specific scaly skin and brittle hair features derive from defects in
the latest stage of differentiating keratinocytes [9,10]. In addition,
reduced b-globin expression and subsequent anemia in TTD
originates from a defective terminal differentiation of precursor
erythrocytes [11]. Furthermore, both TTD and XP/CS patients
and mice express neurological features caused by defects in final-
stage differentiated postmitotic neuronal cells [9,12]. Nevertheless,
many other tissues/organs and cell types appear to be relatively
unaffected. This observation can be partly explained by the
hypothesis that some tissues are more susceptible than others to
endogenous DNA damage [13,14] and/or that TFIIH transcrip-
tional function is differentially regulated in distinct cell types [15].
Most transcription factors, including basal factors and tran-
scription activators, are only very transiently bound, on the order
of a few seconds, to their substrate [16,17]. This uniformly
emerging concept of dynamic transient machineries, with the
exception of components of the actual RNAP2 [18], is thought to
have a number of advantages over previous proposed models
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cell protein mobility studies have culminated in unprecedented,
novel insights into the spatial and dynamic organization of
macromolecule machines within the context of the complex
mammalian cell nucleus with a general, but not universal, modus
operandi of dynamic exchange of reaction constituents (proteins).
Exceptions to this generalmechanism of action have beendescribed
for transcriptional activators, such as Gal4 [19] and hypoxia-
inducible factor 1 (HIF) [20], and for molecular chaperones such as
heat-shock protein 70 [21]. It was found that upon transcription
activation these factors reside longer at the transcription sites.
Interestingly, the basal transcription factor RNAP2 (GFP-RPB3)
was also shown to be longer bound at transcribed regions when
transcription was induced [22,23]. However, it is currently not
known whether the generally observed dynamic kinetic framework
in in situ–cultured cell types for transcription initiation factors, such
as TFIIH [24], can be extrapolated to other cell types in the
organisms, under ground-state transcriptional conditions.
Tostudytheconsequencesofdifferenttranscriptionalprogramson
the kinetic behavior of TFIIH and further understand the complex
phenotypic expression of mutated TFIIH, we created a knock-in
mouse model (Xpb
y/y) that expresses homozygously a YFP (yellow
fluorescent protein, a variant of the green fluorescent protein)-tagged
TFIIH subunit under control of the endogenous transcriptional
regulatory elements. Using this tool, we explored TFIIH binding
kinetics directly in different cells and tissues of the organism.
Results
Generation of the XPB-YFP Knock-In Mouse Model
In order to visualize and quantitatively determine dynamic
interactions of transcription initiation factor TFIIH within
different postmitotic and differentiated cells and living tissues, we
created a mouse knock-in model that expresses the XPB protein
(largest subunit and helicase of the ten-subunit TFIIH complex)
tagged at its C-terminus with the yellow GFP variant (YFP). Gene-
targeting constructs and strategy are schematically depicted in
Figure 1A (see Materials and Methods and Figure S1A for details).
Briefly, the targeting strategy was designed in such a way that
interference of the genomic organization of the Xpb locus was kept
to a minimum, keeping the integrity of the promoter, all the
intron–exon boundaries, and the 39 UTR (including the
endogenous poly A signals) of the Xpb gene intact. The XPB-
YFP fusion protein further contains additional convenient C-
terminal His6- and HA-tags. Embryonic stem (ES) cells transfected
with the targeting fusion construct were selected for proper
targeting (by homologous recombination) by Southern blotting
(Figure S1A). Immunoblotting of whole-cell extracts revealed that
an intact XPB-YFP fusion protein was produced in recombinant
ES cells (Figure S1B). Selected ES cells were introduced in C57Bl/
6 blastocysts and transplanted into foster mothers. Chimeric
offspring were further crossed for germ-line transmission of the
targeted allele (Figure S1D and S1E).
To avoid any possible interference with expression of the fusion
gene by the presence of the dominant selectable NeoMarker in the
39 UTR, heterozygous Xpb
y2Neo/+ mice were crossed with a
ubiquitous Cre-Recombinase–expressing mouse model [25] (Fig-
ure S1D). The subsequent ‘‘floxed’’ heterozygous offspring (Xpb
y/+)
were intercrossed to generate homozygous knock-in mice (Xpb
y/y)
(Figure S1E). Homozygous Xpb
y/y, heterozygous Xpb
y/+, and wild-
type (Xpb
+/+) progeny were obtained in a Mendelian ratio (32
homozygous knock-in mice out of 125 offspring), indicating that
homozygosity for the knock-in fusion gene does not impair
embryonic development. A small cohort of homozygous (males
and females) and heterozygous (six of each) littermates was allowed
to age, until natural death, which occurred around 2 years for both
Xpb
y/y and Xpb
y/+ mice. No obvious features of premature aging or
spontaneous carcinogenesis of the Xpb
y/y other than those
occurring in Xpb
+/+ mice were observed. Knock-in Xpb
y/y mice
appeared healthy and fertile, indicating that the presence of the
fluorescent tag does not significantly interfere with the vital
functions (transcription initiation) of the Xpb gene.
Most viable, naturally occurring TFIIH mutations cause an
overall reduction of the steady-state levels of TFIIH [26–28].
However, comparative immunofluorescence revealed that the
intracellular concentration of p62 (Figure S2A) (another non-
tagged TFIIH subunit) and XPB were not altered by the presence
of the tagged XPB subunit (Figure 1B) [26–28], suggesting that
neither the expression nor the stability was affected by the
presence of the YFP-His6_HA tag on the XPB protein.
Unscheduled DNA repair synthesis capacity (UDS, a measure of
NER activity) after UV damage (Figure S2B) and UV-survival of
Xpb
y/y dermal fibroblasts were similar to wild-type (Xpb
+/+) cells
assayed in parallel (Figure 1C), indicating that the tagged XPB
protein remains normally active in NER. Immunoprecipitation
experiments also showed that the tagged XPB protein was
incorporated into TFIIH (unpublished data), consistent with our
previous observations that exogenously expressed GFP-tagged
XPB is properly incorporated into TFIIH complexes [24].
In conclusion, the addition of the 27-kDa fluorescent tag to the
strongly conserved XPB protein does not detectably affect the
multiple functions of TFIIH in transcription and NER even at the
critical level of an intact organism, whereas single amino acid
substitutions in XPB patients give rise to severe skin cancer
predisposition and dramatic premature aging [29,30]. This
demonstrates that the Xpb
y/y knock-in mouse model is a bona
Author Summary
The accepted model of eukaryotic mRNA production is
that transcription factors spend most of their time
diffusing throughout the cell nucleus, encountering gene
promoters (their substrate) in a random fashion and
binding to them for a very short time. A similar modus
operandi has been accepted as a paradigm for interactions
within most of the chromatin-associated enzymatic
processes (transcription, replication, DNA damage re-
sponse). However, it is not known whether such behavior
is indeed a common characteristic for all cells in the
organism. To answer this question, we generated a knock-
in mouse that expresses in all cells a fluorescently tagged
transcription factor (TFIIH) that functions in both tran-
scription initiation and DNA repair. This new tool, when
combined with quantitative imaging techniques, allowed
us to monitor the mobility of this transcription factor in
virtually all living tissues. In this study, we show that, in
contrast to the aforementioned paradigm, in highly
differentiated postmitotic cells such as neurons, hepato-
cytes, and cardiac myocytes, TFIIH is effectively immobi-
lized on the chromatin during transcription, whereas in
proliferative cells, TFIIH has the same dynamic behavior as
in cultured cells. Our study also points out that results
obtained from in vitro or cultured cell systems cannot
always be directly extrapolated to the whole organism.
More importantly, this raises a question for researchers in
the transcription field: why do some cells opt for a
dynamic framework for transcription, whereas others
exhibit a static one?
Dynamics of TFIIH in Living Tissues
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dynamic organization of transcription and DNA repair in vivo in
an intact organism. Fluorescence of TFIIH was detectable in all
primary cultures of different cell types isolated from these mice,
e.g., ES cells, dermal fibroblasts, and keratinocytes (Figure S2C).
Note that the level and subnuclear distribution of fluorescence
throughout the cell population is homogeneous (Figure S2C), in
striking contrast to the heterogeneous expression characteristic of
stably transfected cell cultures.
TFIIH Mobility Is Different in Distinct Living Tissues
To study the spatiotemporal distribution of TFIIH and to
determine its kinetic engagements in different cell types within
intact tissues, we established organotypic cultures of several organs
and tissues. Within organotypic slices of cerebral cortex, isolated
and maintained according to established procedures [31], the
different cortex layers and the neurons are easily recognizable
(Figure S3A). We determined live-cell protein mobility of TFIIH
by fluorescence recovery after photobleaching (FRAP) (see
Figure 2A, top panel, and Materials and Methods). Using
exogenously expressed XPB-GFP, we previously demonstrated
that TFIIH in SV40-immortalized human fibroblasts is highly
dynamic: the majority moves freely through the nucleus, and a
fraction transiently interacts with promoters for only a few seconds
(2–6 s) [24]. We found a similar high mobility in primary
keratinocytes when monitored within the epidermis of skin
explants from Xpb
y/y mice (Figure 2A, middle panel), where
fluorescence fully recovered in the bleached strip within a few
seconds. In sharp contrast, FRAP on neurons within cerebral
cortex slices revealed a striking incomplete fluorescence recovery,
even after 60 min postbleaching (Figure 2A, lower panel, and
Figure S3B), indicating an unprecedented large (.80%) immobile
pool of TFIIH (Figure 2B) stably bound to static nuclear
structures, most likely chromatin. This unexpected static behavior
of a transcription initiation factor, which can be compared to the
static behavior of H2B in cultured cells [32], was also observed in
Purkinje cells and cerebellar granular neurons in organotypic slices
(Figure 2C and Figure S4) suggesting that this behavior is a
common feature in various neurons, despite their different
functions, chromatin compaction, and different TFIIH expression
levels (Figure S5A). Moreover, computation of the (squared)
Pearson product moment correlation coefficient between mea-
sured immobile fractions and single-cell TFIIH expression levels
showed no significant linear relation between these parameters
(r
2=0.062). We also measured the mobility of nonfused GFP in
neurons within organotypic cerebellar slices derived from a mouse
Figure 1. Generation and characterization of a mouse model expressing XPB-YFP
His2HA fused protein. (A) Schematic presentation of
the 39 part of the mouse Xpb gene locus, including the last exons 14 and 15. The dotted line indicates the 7-kb mouse genomic DNA fragment used
for gene targeting. The translational stop codon (in exon 15) was mutated to allow in-frame fusion with the modified fluorescent marker, YFP (i.e.,
ATG-less YFP, with an additional stretch of six histidines and an HA epitope tags). As a dominant selectable marker, a neomycin cassette (flanked by
two LoxP sites) was introduced downstream the YFP sequence. Details of the targeting strategy are presented in Materials and Methods. (B)
Percentage of surviving cells, 48 h after UV irradiation at the indicated doses of dermal fibroblasts isolated from Xpb
+/+ mice (wild-type [wt], green),
Xpb
y/y mice (red), and Xpb
y/y mice crossed with Xpc (NER-deficient) mice (blue). (C) Comparative immunofluorescence of a mixed population of dermal
fibroblasts isolated from an untargeted mouse (Xpb
+/+, HA negative) and a targeted mouse (Xpb
y/y, HA positive), stained with anti-XPB (red, left) or
anti-HA (green, right), which recognizes the XPB-YFP-His6HA protein. Bar: 10 mm.
doi:10.1371/journal.pbio.1000220.g001
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PLoS Biology | www.plosbiology.org 3 October 2009 | Volume 7 | Issue 10 | e1000220Figure 2. Mobility of TFIIH in cultured cells and in living tissues. (A) FRAP assay (upper panel) and confocal images of keratinocytes (middle
panel) and cortex neurons (lower panel) within tissue sections during FRAP analysis. A small region in the middle of the nucleus is bleached; the
subsequent recovery is followed in time for 10 min. Fluorescence is quickly recovered in keratinocytes (less than 10 s; see Figure 2B), whereas in
neurons after 10 min, fluorescence in the bleached area is still not fully recovered. Bar: 20 mm. (B) FRAP graph in which the relative fluorescence (Rel.
Fluorescence) recovery after bleaching is plotted against time (seconds). The recovery curve of keratinocytes is shown in red and the curve from
cortex neurons in blue. (C) TFIIH bound fractions in different cells, calculated as described in Materials and Methods. Amount of immobilized TFIIH is
indicated as percentage of the total amount of TFIIH. Error bars represent the standard error of the mean. Rel.: relative.
doi:10.1371/journal.pbio.1000220.g002
Dynamics of TFIIH in Living Tissues
PLoS Biology | www.plosbiology.org 4 October 2009 | Volume 7 | Issue 10 | e1000220that expressed GFP under the control of actin promoter [33]. In
contrast to TFIIH mobility, GFP itself diffuses very rapidly in
neurons (Figure S5B), as was previously found in cultured cells
[34,35]. These results indicate that this static behavior is specific
for TFIIH and not a common phenomenon of nuclear protein
mobility in neurons.
Mobility of TFIIH in Neurons Reflects TFIIH Cellular
Engagement in Transcription
How does TFIIH immobilization relate to its multiple biological
activities? Obviously, the engagement of TFIIH in transcription is
most relevant in tissue sections not treated with DNA-damaging
agents. However, to exclude that an eventual NER-dependent
binding activity could account for the immobilized TFIIH in
neurons, initiated by a possible high load of endogenously
produced lesions, we measured TFIIH mobility in NER-deficient
mice. For this purpose, we crossed Xpb
y/y mice with Xpc
2/2,t o
generate Xpb
y/yNXpc
2/2 mice. In the absence of XPC, TFIIH
does not bind damaged DNA [36]. TFIIH mobility in neurons
from Xpb
y/yNXpc
2/2 mice appeared identical as in neurons
derived from NER-proficient mice (Figure 3A and Figure S6),
showing that the DNA repair function of TFIIH is not responsible
for the protracted binding of TFIIH. To demonstrate that the
transcription function is responsible for TFIIH immobilization, we
inhibited transcription by treating organotypic brain slices with the
RNAP2-specific transcription inhibitor a-amanitin [37]. a-Ama-
nitin blocks the catalytic domain of RNAP2 [38], inhibiting both
transcription initiation and elongation. Treatment of organotypic
tissues with a-amanitin resulted in a release of immobilized TFIIH
(Figure 3A and Figure S7), suggesting that the immobilization is
due to the transcriptional function of TFIIH [17,24]. In parallel,
we verified that the condition used (incubation time and drug
concentration) for transcription inhibition in tissues blocked
transcription in cultured cells by measuring the BrU incorporation
(Figure S8A and S8B). To further prove that the transcriptional
engagement of TFIIH causes its high immobilization in neurons,
we modulated transcription by inducing a cold shock (4uCo r
27uC). As with the heat-shock response, cold shock generally
induces a reduction in basal transcription and translation and a
growth arrest [39]. This response is temporary, since after an
adaptation period, cellular metabolism is resumed, although at a
lower rate compared to growth at 37uC [40]. Moreover, after cold
shock, a change in global expression of genes is observed [41] to
allow adaptation to this environmental stress. As shown in
Figure 3A and Figure S7, reducing the temperature of
organotypic slices to extreme (4uC) and moderate hypothermia
values (27uC) for 30 to 60 min fully remobilized TFIIH in
neurons. To check whether this is a temporary stress response, we
also measured the mobility of TFIIH in neurons embedded in
organotypic slices kept at 27uC for 48 h. Under these conditions,
TFIIH was found to bind as in untreated organotypic slices
(37uC), demonstrating that the remobilization of TFIIH at low
temperatures is a rapid (60 minutes at 4uCo r2 7 uC) temporary
response, likely reflecting a change in the transcriptional
engagement (Figure 3A and Figure S7).
Additionally to RNAP2 transcription, TFIIH has been found to
accumulate in nucleoli and participate in RNAP1 transcription
[24,42]. Although the clear TFIIH function in RNAP1 transcrip-
tion has not been elucidated yet, dynamic studies showed that
TFIIH residence time in RNAP2 transcription (2–10 s) is different
from RNAP1 transcription (,25 s), suggesting that the role played
by TFIIH in these two cellular functions could be slightly different
[24]. Cortex neurons and Purkinje cells show a strong localization
of TFIIH in nucleoli (Figure S9A), allowing local FRAP analysis in
this subnuclear compartment. Similarly to nucleoplasmic TFIIH
immobilization (RNAP2 transcription), nucleolar TFIIH immobi-
lization (RNAP1 transcription) was also very high (Figure 3A and
Figure S10). In contrast, however, this immobilization is partly
resistant to cold shock and resistant to a-amanitin treatment, in
line with the expectation, as a-amanitin is known to exclusively
inhibit RNAP2 transcription (Figure 3A and Figure S8). To
determine that moderate cold shock would indeed inhibit RNAP1
transcription, we measured the amount of pre-rRNA 45S in cold
shock–treated cells and tissues (organotypic brain cultures).
Surprisingly, cold shock did not alter the amount of 45S, either
in cultured cells or in organotypic cortex slices (Figure S9B). The
absence of a reduction of the steady-state-levels of 45S rRNA by
either a severe (4uC) or a mild (27uC) cold shock is likely explained
by the fact that cold shock also interferes with pre-rRNA
maturation or degradation. In fact, some proteins, induced by
cold shock, have been showed to play a role in preventing the
degradation of RNA molecules (reviewed in [43]). In contrast,
RNAP1 transcription inhibition induced by actinomycin D
(0.1 mg/ml) led to a clear reduction of the amount of pre-rRNA
in cultured cells. In conclusion, our results suggest that TFIIH is
highly immobilized in neurons in both RNAP2 and RNAP1
transcription.
As TFIIH is known to be involved in RNAP2 transcription
initiation, its transcription-dependent immobilization in neurons
predicts a favored binding of TFIIH at promoter sequences. To
verify that indeed TFIIH in cortex neurons was bound to
promoters of active genes, we performed chromatin immunopre-
cipitation (ChIP) on adult cortex tissues slices under normal
conditions and after cold shock, and measured the proportion of
active housekeeping genes (xpb, RnaPolI) promoter sequences
versus adjacent untranscribed areas by semiquantitative PCR
(Figure 3C and Figure S9D). As shown by the FRAP experiments
(Figure 3A and Figure S7), during cold shock, TFIIH is released
from chromatin (Figure 3B). Importantly, we found that TFIIH in
cortex slices is more strongly bound to promoter sequences (40%
of the input genomic DNA) than to untranscribed areas (19%) (see
Materials and Methods for details, Figure 3C and Figure S9D).
However, after cold shock, TFIIH is less bound to promoters,
clearly showing that cold shock–induced transcription inhibition is
associated with remobilization of TFIIH from housekeeping gene
promoters.
In view of the notion that the majority of TFIIH is immobilized
to chromatin, we wondered whether TFIIH would be available to
act in NER after a sudden high dose of genotoxic stress. Since
neurons located in the slice are inaccessible to UV-C light, we used
multiphoton laser irradiation to locally induce DNA damage
[44,45] in cerebral neurons and compared the accumulation of
TFIIH to that observed in skin keratinocytes damaged by the same
procedure. Surprisingly, despite the large fraction of immobilized
TFIIH, significant amounts of TFIIH were still recruited to
damaged DNA (Figure 3D).
Transcription Organization Varies during Development
Since the observed high TFIIH immobilization is not found in
all cell types (Figure 2C), we exploited the availability of an entire
organism to analyze the dynamic distribution of TFIIH in
different cell types within the context of living tissues (Figure 4A
and Figure S11). Specifically in postmitotic and nonproliferative
cells (neurons, myocytes, and hepatocytes), we identified a large
pool of immobilized TFIIH, whereas in proliferating cells and/or
cells that have the capacity to proliferate (intestine epithelium,
epidermal keratinocytes, and dermal fibroblasts), TFIIH was
found to be highly mobile (Figure 4A and Figure S11). This would
Dynamics of TFIIH in Living Tissues
PLoS Biology | www.plosbiology.org 5 October 2009 | Volume 7 | Issue 10 | e1000220Figure 3. Mobility of TFIIH in cortex neurons during transcription and repair. (A) TFIIH bound fractions in cortex neurons from Xpb
y/y mice
treated with a-amanitin (transcription inhibition) or submitted to a cold-shock treatment (4uCo r2 7 uC) for 1 h and 2 d (27uC); the effect on TFIIH
mobility was compared to the untreated samples (unt). To measure TFIIH dynamics during Pol 2 transcription, measurements were conducted in the
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factor would be determined by the proliferative capacity of cells.
However cultured chondrocytes maintained in a confluent state
under low serum were shown to become quiescent (as shown by
the absence of the Ki67 marker, Figure S12A) and did not show a
difference in TFIIH mobility when compared with proliferative
chondrocytes (Figure S12B), suggesting that absence of prolifer-
ation is not a condition sufficient to cause a reduction in TFIIH
mobility. In view of this result, we investigated whether TFIIH
mobility is affected during the establishment of a differentiation-
dependent specific transcriptional program. We measured TFIIH
mobility during postnatal development of cerebral cortex and
liver. Brain and liver were isolated from pups at different postnatal
days (PNd), and TFIIH mobility was measured in cortex neurons
and hepatocytes. Remarkably, we observed a progressive TFIIH
immobilization during development (Figure 4B and Figure S13)
(Figure 4C and Figure S14), which appeared time- and organ-
specific. In cortex neurons, TFIIH bound fractions are gradually
increasing from PNd 10 (Figure 4B and Figure S13). TFIIH
mobility in neurons is very homogeneous throughout the tested
population of cells at each different developmental stage, whereas
in liver during development at, e.g., PNd 6, the kinetic pools differ
over the population (see inset, Figure 4C) and becomes
homogeneous at later stages. Our results demonstrate that the
strong TFIIH binding is a physiological event that takes place
during normal development of organs and suggests the establish-
ment of a more fixed transcriptional program than in rapidly
growing cells.
Mobility of TFIIH in Differentiated Cells In Vivo and In
Vitro
To further investigate differentiation-dependent mobility of
TFIIH, we used an in vivo keratinocyte differentiation model.
Within the hair shaft, highly differentiated nonproliferative
keratinocytes, known as trichocytes [46], can be found. These
cells produce the keratins and keratin-associated proteins that form
the structure of hairs. Trichocytes are easily recognizable because
of their position in the hair and of the melanin inclusions in their
cytoplasm (Figure 5A, left panel). Indeed, in trichocytes (Figure 5B
and Figure S15), TFIIH mobility is greatly reduced, almost to the
same extent as in neurons and myocytes, whereas in other
keratinocytes of the hair follicle (bulb) (Figure 5A, right panel),
TFIIH is highly mobile (Figure 5B and Figure S15). To
substantiate that indeed differentiation is an important determi-
nant for the observed shift in TFIIH mobility, we measured TFIIH
mobility during in vitro differentiation. ES cells were nonspecif-
ically differentiated using the hanging drop technique [47].
Through the use of this method, several differentiated cell types
can be obtained, organized in morphologically different areas of a
developing clone. We measured different cells in several
morphologically distinct regions of the differentiated ES clones.
In these clones, three distinct TFIIH mobility groups were
observed (Figure 5C and Figure S16). The vast majority of cells
(,70%) presented a high TFIIH mobility, a second group (,20%)
presented an intermediate (,40%) bound fraction of TFIIH, and
a small fraction of cells (,10%) presented a high TFIIH binding
capacity (. than 70%). Postlabeling showed that cells with high
TFIIH binding were mainly osteocytes (Figure S17A and S17B).
During ES hanging drop differentiation, cardiac myocytes were
produced in culture. Morphologically indistinguishable from other
cell types, however, cardiac myocytes have the property to beat in
vitro, making them easily recognizable, but not easily measurable.
Addition of Ca
2+-free medium impedes cardiac myocytes beating,
allowing measuring of TFIIH mobility in these differentiated cells.
In these cells, we measured a TFIIH bound fraction of 43%, an
intermediate fraction between the mobility observed in cardiac
myocytes in situ and the undifferentiated ES cells. All together, our
results show that during cellular differentiation of some cell types
(neurons, hepatocytes, osteocytes, thricocytes, and myocytes), the
dynamic organization of the basal transcription machinery is
radically changed, whereas in other cell types (keratinocytes,
fibroblasts, and chondrocytes), the dynamic framework of TFIIH
activity is maintained.
Discussion
Previous live-cell studies on complex multifactorial chromatin-
associated processes that take place in mammalian cell nuclei, such
as transcription, replication, and various DNA repair processes,
have disclosed a general model in which highly mobile proteins
(process factors) interact with sites of activity (e.g., promoters or
DNA lesions) on the basis of stochastic collisions to form transient
local machineries in an ordered but highly versatile manner
[16,48,49]. These biologically relevant novel concepts, however,
have been obtained mainly by exogenous expression of tagged
factors within highly replicative cells in culture.
In an attempt to study the essential basal transcription initiation
factor TFIIH within cells embedded in their natural environment
(tissue), we designed a mouse model that allows quantitative
determination of TFIIH dynamics. Using carefully designed
targeted integration of the live-cell marker YFP at the Xpb locus
(expressing the TFIIH subunit XPB), we obtained expression of
functional YFP-tagged XPB protein under control of the
endogenous promoter (guaranteeing physiological expression);
we now find evidence for a fundamentally different scenario for
the organization of basic transcription initiation in some cell types
in the organism. Postmitotic cells (neurons, myocytes, and
hepatocytes, etc.) appear to apply a largely static organization of
transcription initiation with components being stably bound to
chromatin that otherwise in other cell types (fibroblasts, chondro-
cytes, and keratinocytes, etc.) exchange constantly in a highly
dynamic manner. In postmitotic cells, TFIIH is bound to
promoters with a much longer residence time than in proliferative
cells. A possible explanation for this static behavior is that in these
nucleoplasm (blue square); to measure TFIIH dynamics during Pol 1 transcription, measurements were conducted in the nucleoli (red square). TFIIH
bound fractions were measured in cortex neurons from Xpb
y/yNXpc
2/2 (NER-deficient) mice (green square). Error bars represent the standard error of
the mean. Rel.: relative. (B) Equal amounts of sonicated chromatin solution were analyzed on SYBR Green–stained agarose gel after proteinase K
treatment and reversal of the cross-links (lane 1 and 2). Following sonication, HA-antibody was added to the chromatin solution for
immunoprecipitation of TFIIH complex. Equal volume of immunoprecipitated DNA fraction complex was loaded on gel (lane 3 and 4). (C)
Semiquantitative PCR on 200 ng of genomic DNA (gDNA) and 200 ng of HA-precipitated chromatin from cortex slice incubated at 37uC and 4uC.
Promoter sequence from the XPB gene (2143/2274) and untranscribed region adjacent to the XPB gene (chr 18: 32479000–32478600) were
amplified. PCR products were quantified and plotted on a bar graph: the y-axis represents the percentage of amplified sequences from the HA-
precipitated chromatin versus amplified sequences from gDNA. Asterisk (*): undetectable. Error bars have been calculated for three biological
replicates. (D) TFIIH accumulation after multiphoton laser induction of DNA damage in cortex neurons (upper panel) versus cultured keratinocytes
(lower panel). Images are taken before and after the damage at different indicated time points. Bar: 10 mm.
doi:10.1371/journal.pbio.1000220.g003
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PLoS Biology | www.plosbiology.org 8 October 2009 | Volume 7 | Issue 10 | e1000220postmitotic terminally differentiated cells, a large part of the
transcription program is dedicated to a specific subset of genes
defining cellular specialty and housekeeping functions, without the
need to continuously switch to transcribed genes that are involved
in proliferation (cell cycle, replication, and mitosis, etc.). It is
possible that regular replication of the genome in proliferating
(cultured) cells and tissues causes a continuous resetting of the
transcription regulation machinery after each round of cell
division and, in parallel, would involve a more open and accessible
chromatin conformation.
It is generally accepted that differentiation requires and causes a
resetting of the transcriptional program by activating and down-
regulating specific genes in response to internal and external
stimuli, thereby utilizing lineage-specific transcription activators
and/or repressors. However, here, we have identified a novel
concept of differentiation-dependent spatio-temporal organization
of transcription initiation. This concept implies that transcription
initiation factors, such as TFIIH, will be bound to promoters much
longer in certain cell types than in others (Figure 6). Previously,
differences in dynamic associations of lineage-specific transcrip-
tional activators [50,51] and elongation factors [21,52] have been
linked to activation of transcription. However, the herein
described dynamic association of the basal initiation factor TFIIH
in neurons, hepatocytes, and myocytes is likely not linked to a
higher level of transcription than in, for example, keratinocytes,
fibroblasts, or ES cells. We propose a model that the observed low
mobility of TFIIH in highly differentiated postmitotic cells is
derived form the establishment of a differentiation- and lineage-
Figure 4. Mobility of TFIIH in different cell types and during development. (A) TFIIH bound fractions are determined in different (indicated)
cell types in their tissue. Rel.: relative. (B) TFIIH bound fractions determined at different stages of brain development. PNd, postnatal day. (C) TFIIH
bound fractions during different stages of liver development. The insert shows two distinct groups of cells having two different levels of TFIIH
immobilization. The error bars represent the standard error of the mean.
doi:10.1371/journal.pbio.1000220.g004
Figure 5. Mobility of TFIIH during in vivo and in vitro differentiation. (A) Left panel: image (bar: 10 mm) of the hair shaft with trichocytes; the
dotted circle indicate the body of a trichocyte. Right panel: image of a hair bulb; the dotted line indicates the limit of the hair (bar: 50 mm). Within the
hair shaft, cuticle cells are recognizable. M, cytoplasmic melanin inclusions; N, nucleus. (B) TFIIH bound fractions determined in proliferative and
differentiated keratinocytes in the tissue. Rel.: relative. (C) TFIIH bound fractions within different populations of in vitro differentiated ES cells and
mature heart myocytes within the heart muscle. The error bars represent the standard error of the mean.
doi:10.1371/journal.pbio.1000220.g005
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is not a general differentiation-dependent phenomenon because in,
e.g., fibroblasts, chondrocytes, and keratinocytes, although differ-
entiated, a much higher mobility of TFIIH is present. This
observation excludes that this phenomenon is caused by a general
change in mobility of histones during ES differentiation, as was
previously described [53].
The fast TFIIH remobilization observed in neurons after a cold
shock or the induction of local DNA damage demonstrates that,
within neurons, TFIIH is still able to respond promptly to a ‘‘stress
situation’’ that requires a rapid adaptation of the transcriptional
program (in the case of the cold-shock response) or to be implicated
in DNA repair. Thus remarkably, the static involvement of TFIIH
in transcription initiation does not interfere with the flexibility of
cells to change the nuclear organization in response to changing
conditions. It is of interest to know how multifunctional factors such
as TFIIH are still able to switch from one functional role to another
and to relocate to other activity sites despite their virtually immobile
nature. Further analysis is required to identify which subroute of
NER (global genome NER, transcription-coupled NER, or
differentiation-associated repair [DAR] [54]) is employed to repair
genomic injuries in differentiated cells or whether lesions in
permanently inactive sequences are repaired at all. The strategy
outlined here has allowed us to address how transcription is
organized in fully differentiated tissues or organs and during
differentiation and development. Insights into these processes at the
level of an intact organism are also relevant for a better
understanding of the molecular basis of cancer and aging-related
pathology. Importantly, our mouse model can be crossed into
different genetic backgrounds, including existing TFIIH mutated
mouse models [12,55], mutated in another TFIIH subunit, i.e.,
XPD. These mice are associated with a puzzling clinical
heterogeneity ranging from cancer predisposition to dramatically
accelerated aging [1,6–8,12,55]. For instance, investigating TFIIH
engagements directly in affected cells (neurons) in living tissues of
XP/CS or TTD mice, which harbor a mutation in one of the other
TFIIH components (XPD) [56], will help to elucidate the peculiar
phenotype observed in these syndromes.
Materials and Methods
Ethics Statement
All animal work have been conducted according to Federation
of European Laboratory Animal Science Associations (FELASA)
ethical requirements and according to the respect of the 3R animal
welfare rules.
Generation of the Targeting Construct
The knock-in targeting vector (backbone pGEM5ZF) consisted
of an approximately 7 Kb (NsiI/SalI fragment) mouse genomic
Figure 6. Schematic model of TFIIH switch in mobility during differentiation. Schematic illustration of the nucleus of a proliferative (left)
and a postmitotic (right) cell. Green lines (left) and red lines (right) identify the promoter regions. Orange arrows depict the transcriptional start. PIC
represents the preinitiation complex. RPBII represents the RNA polymerase II. The arrow width indicates the preferential direction of the equilibrium.
doi:10.1371/journal.pbio.1000220.g006
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locus. The locus was modified by site-directed mutagenesis (SDM)
to transform the stop codon into a coding amino acid (tryptophan)
and two unique restriction sites were inserted for cloning purposes
(i.e., SacII at the stop codon and NotI at a distance of 20 bp
downstream of the SacII site). Between the SacII and NotI, a
modified YFP was cloned, the YFP start was modified into a valine
to avoid undesired translation of nonfused YFP. The YFP gene
was further tagged at the C-terminus with a stretch of six histidines
and an HA epitope sequence. A unique ClaI site was created
10 bp downstream of the stop codon of the modified YFP to
introduce a neomycin gene-expression cassette, flanked by two
LoxP sites [57], used as a dominant selectable marker. The
dominant marker was inserted in the same transcriptional
orientation as the Xpb gene.
ES Cell Culture and Gene Targeting
ES cells (129 Ola, subclone IB10) were cultured in BRL-
conditioned medium supplemented with 1,000 U/ml leukemia
inhibitory factor. A total of 20 mg of the PmeI linearized targeting
vector was electroporated into approximately 10
7 ES cells in
500 ml. Selection with 0.2 mg/ml G418 was started 24 h after
electroporation. After 8–10 d, G418 resistant clones were isolated.
Screening for homologous recombinants was performed using
DNA blot analyses of NcoI-digested DNA with a 400-bp 59
external probe (see Figure 1A and Figure S1A). Out of 128 G418
resistant clones, 12 ES clones had a correctly targeted Xpb allele.
Two out of the 12 correctly targeted ES clones, checked for proper
caryotype, were injected into blastocysts of C57Bl/6 mice and
transplanted into B10/CBA foster mothers. Chimeric mice were
further crossed, and germline transmission of the targeted allele to
offspring was genotyped by PCR using primer sets (as described in
Figure S1) and genotyping of offspring was done by PCR (see
Figure S1). Primers sequences are available on request.
Mice
The knock-in Xpb
y (resulting fusion gene between Xpb and YFP,
coding for XPB-YFP) allele was maintained in both FVB and
C57BL/6 backgrounds. We thank P. Vassalli for pCAGGSCre
plasmid used to generate the transgenic CAG-Cre recombinase–
expressing mice. EGFP-expressing mice were kindly provided by
Dr. Okabe [33] and Dr. R. Torensma (Nijmegen).
Cell Culture and Specific Treatments
Murine dermal fibroblasts (MDF) were extracted from Xpb
+/+,
Xpb
y/y, and Xpb
y/yNXpc
2/2 mice, following established procedures
[58] and cultured in a 1:1 mixture of Ham’s F10 and DMEM
(Gibco) supplemented with antibiotics and 10% fetal calf serum at
37uC, 3% O2, and 5% CO2. To induce in vitro differentiation of
XPB-YFP–expressing ES cells, we applied the hanging drop
method [47]. Briefly, 20 ml of ES cell suspension (2610
5/ml in
DMEM [Lonza] with 20% fetal calf serum [Lonza], 50 U
penicillin/ml, and 50 mg streptomycin/ml [Lonza], 1% nonessen-
tial amino acids [Lonza], 0.1 mM B-mercaptoethanol [Sigma])
were placed on the lids of Petri dishes filled with PBS. After
culturing for 3 d, the aggregates were transferred into bacterio-
logical Petri dishes. Two days later, embryoid bodies were placed
in Costar six-well plates with gelatin-coated coverslips for further
development into different cell tissues. From day 3 on, retinoic
acid (10
28 M) was added to induce skeletal muscle differentiation.
Treatment with ultraviolet (UV) light at 254 nm (UV-C) was
performed using a Philips germicidal lamp. For UV-survival
experiments, cells were exposed to different UV-C doses, 2 d after
plating. Survival was determined 3 d after UV irradiation by
incubation at 37uC with
3H-thymidine, as described previously
[59]. For unscheduled DNA synthesis (UDS), cells were exposed to
8 J/m
2 of UV-C and processed as described previously [28].
Organotypic Cultures
Organotypic explants of cerebral cortex and cerebellum were
produced as previously described [31,60]. Tissues were analyzed
on the same day of extraction in Neurobasal-A (GIBCO) medium,
supplemented with antibiotics and B-27 at 37uC, 3% O2, and 5%
CO2. FRAP analysis on cells within organotypic slices, maintained
in culture for 1 wk, gave the same results as when performed on
freshly extracted slices. Organotypic slices of heart, liver, and
intestine were produced by cutting 300 mm of the organ with a
Tissue Chopper (McIllwain). Slices were analyzed within 2 h
following preparation, unless differently specified in the text. Skin
tissues (epidermis and dermis) were prepared as described [10].
Before imaging, the two layers were mechanically separated and
mounted on a coverslip for imaging and analysis.
Immunoblot Analysis
Whole-cell extracts (WCE) of Xpb
+/+ and Xpb
y/+ ES cells were
prepared by isolating cells from a semiconfluent Petri dish (10 cm).
Cells were washed with phosphate-buffered saline (PBS) and
homogenized by sonication. Western blot analysis was performed
as previously described [1].
Comparative Immunofluorescence Assays
A mixture of Xpb
+/+ and Xpb
y/y cells were grown on glass
coverslips and fixed with 2% paraformaldehyde at 37uC for
15 min. Immunofluorescence analysis was carried out as previ-
ously described [1]. Antibodies use were a rabbit polyclonal anti
XPB (1:500, S-19, Santa Cruz Biotechnology), a mouse monoclo-
nal anti-p62 (1:1,000, 3C9, kindly provided by Dr. J. M. Egly), and
a rat monoclonal anti-HA (1:1,000, 3F10, Roche).
Fluorescence Recovery after Photobleaching (FRAP) and
Calculation of TFIIH Bound Fractions
FRAP experiments were performed as described before [24,61]
at high time resolution on a Zeiss LSM 510 meta confocal laser
scanning microscope (Zeiss). Briefly, a narrow strip spanning the
nucleus of a cell was monitored every 200 ms at 1% laser intensity
(30 mW argon laser, current set at 6.5 A, 514-nm line) until the
fluorescence signal reached a steady level (after circa 4 s). The
same strip was then photobleached for 60 ms at the maximum
laser intensity. Recovery of fluorescence in the strip was then
monitored every 200 ms for about 30 s (1% laser intensity). All
FRAP data was normalized to the average prebleached fluores-
cence after removal of the background signal. Every plotted FRAP
curve is an average of at least ten measured cells.
To estimate the relative TFIIH bound fractions (BF) from the
FRAP measurements, we used the first data point after photobleach-
ing (Fmin) as an approximation of the baseline fluorescence recovery
(BF=1), i.e., the fluorescence level in the absence of recovery, when
all proteins are considered immobile. We calculated the time-average
fluorescence signal taken between 2 and 3.9 s prior to the
photobleaching step to obtain the average prebleach fluorescence
(Fpre),and then between 10 and 15 sto estimate the final fluorescence
recovery level (Fmax). The bound fraction is then given by:
BF~1{ Fmax{Fmin ðÞ

Fpre{Fmin

:
We corrected for the photobleached fraction, i.e., the
incomplete recovery of fluorescence due to irreversible YFP
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cultured keratinocytes were first imaged, subsequently strip-
bleached (60-ms photobleach at maximum laser intensity), then
imaged immediately after the bleach pulse and again 1 min later
when no traces of the bleached strip were observed. The
photobleached fraction (PBF) relative to the baseline fluorescence
recovery (Fmin) was estimated as the average fluorescence intensity
loss between the prebleached image (Fnucleus (pre)) and the last
image of the nucleus (Fnucleus (last)):
PBF~1{ Fnucleus last ðÞ { Fmin ðÞ ð = Fnucleus pre ðÞ {Fmin ðÞ :
The corrected bound fraction is then given by:
BFcorr~ BF{PBF ðÞ = 1{PBF ðÞ :
Note: Measuring conditions where designed solely to measure
immobile fractions, not diffusion or dissociation constants.
Multiphoton Laser-Induced DNA Damage
Laser-induced DNA damage was conducted as previously
described [45]. Briefly, a Coherent Verdi pump laser with a Mira
900 mode locked Ti:Sapphire laser system (Coherent) was directly
coupledtoaLSM510NLOmicroscope(Zeiss)toobtainan800-nm
pulsed output (200-fs pulse width at 76 MHz, 10 mW output at the
sample). Single nuclei targeted with the multiphoton laser received
an approximately 250-ms exposure restricted to a 1-mm-wide strip.
Chromatin Immunoprecipitation (ChIP)
The applied ChIP protocol was adapted from previously
described methods [62,63]. Briefly, brain fragments were fixed
by adding 11% formaldehyde solution containing 50 mM Hepes
(pH 8), 1 mM EDTA, 0.5 mM EGTA, and 0.1 M NaCl to a final
concentration of 1% and incubated for 15 min at room
temperature and 1 h at 4uC. Cross-linking was stopped by
addition of glycine to a final concentration of 0.125 M. Fragments
were washed twice with cold phosphate-buffered saline and treated
with lysis buffer (50 mM Hepes [pH 8], 140 mM NaCl, 1 mM
EDTA, 0.5 mM EGTA, 10% glycerol, 0.5% NP-40, 0.25%
Triton X-100) containing 1 mM PMSF and a mixture of protease
inhibitors. Fragments were homogenized (Ultra turrax, T25 basic),
and ground on ice with an A-type and B-type glass pestle (20
strokes each) to allow nuclei release. Nuclear suspension was then
sheared extensively by sonication on ice to obtain fragments of 200
to 600 bp (as revealed by ethidium bromide staining of aliquots
run on agarose gels). For each ChIP reaction, 100 mg of cross-
linked chromatin was immunoprecipitated with 0.5 mg of HA-
antibody in RIPA buffer (10 mM Tris-HCl [pH 8], 1 mM EDTA,
0.5 mM EGTA, 140 mM NaCl, 1%Triton X-100, 0.1% Na-
deoxycholate, 0.1% sodium dodecyl, 1 mM PMSF, and a mixture
of protease inhibitors) overnight. The immunocomplexes were
collected by adsorption (3 h) to precleared protein G sepharose
beads (Upstate) precoated in RIPA containing 0.1 mg/ml
sonicated salmon sperm DNA (ssDNA). The beads were then
washed twice with 20 volumes of RIPA and once with RIPA
containing ssDNA (Sigma), and twice with RIPA containing
ssDNA and 0.3 M NaCl. Finally, the beads were washed with 20
volumes of LiCl buffer (10 mM Tris-HCl [pH 8], 1 mM EDTA,
0.5 mM EGTA, 0.25 M LiCl, 0.5% triton X-100, 0.5% Na-
deoxycholate, 1 mM PMSF, and a mixture of protease inhibitors),
resuspended in RIPA buffer, and divided into two equal parts to
analyze coprecipitating proteins and DNA sequences.
DNA Extraction after ChIP and PCR Reaction
For DNA analysis, the immunocomplexes were treated with
RNAse (5 mg/ml) for 30 min at 37uC and by proteinase K
(200 mg/ml) 3 h at 55uC in 50 mM Tris-HCl (pH 8), 1 mM
EDTA, 100 mM NaCl, 0.5% SDS. Formaldehyde cross-links
were reverted by heating the samples at 65uC for 6 h. The cross-
linked DNA was extracted with phenol:chloroform and precipi-
tated with ethanol in the presence of carrier glycogen. Pellets were
resuspended in 30 ml of distillated water. Chromatin-immunopre-
cipitated DNA was subjected to PCR amplification. PCR was
performed using 200 ng (for promoter XPB gene amplification)
and 100 ng (for untranscribed sequences) of the chromatin
immunoprecipitate and 400 nM concentration of both sense and
antisense primers (primer sequence available upon request) in a
final volume of 25 ml using the PureTaq Ready-to-go PCR beads
(GE Healthcare). PCR products were analyzed on 2% agarose7
gels by SYBR Green reagent. Data were analyzed and quantified
using Quantity One program (Bio-Rad). For adjustment of
amplification efficiency of each primer set, PCR signal intensities
from chromatin-immunoprecipitated DNA were normalized to
those from the input genomic DNA and expressed as a percentage
of the input (gDNA).
RNA Extraction and Reverse Transcriptase PCR Reaction
Brain slices and cultured cells were incubated at 37uC and 4uC.
Additionally, cultured cells were incubated with 0.1 mg/ml of
actinomycin D for 2 h. Samples were homogenized in Trizol using
the Tissuelyser (Qiagen) for 90 s. RNA isolation was performed
using the RNeasy Mini Kit (Qiagen). cDNA was produced using
2 mg of RNA with a Reverse Transcription Kit (Invitrogen),
random primers (Invitrogen), 1 mg of cDNA, and 400 nM
concentration of both sense and antisense primers (primer
sequence and PCR cycle available upon request) in a final volume
of 25 ml using the PureTaq Ready-to-go PCR beads (GE
Healthcare). PCR products were analyzed on 2.5% agarose gels.
Supporting Information
Figure S1 Analysis of the Xpb gene targeting. (A) Southern
blot analysis of genomic DNA (NcoI digest) from IB10 ES cells
(OLA 129) electroporated with the targeting construct (Figure 1A
and Materials and Methods) to identify clones with proper gene
targeting by homologous recombination, using a part of exon 14
(Xpb) as an external probe (not included in the targeting construct),
indicated as a yellow bar. The genomic organization, including
relevant restriction sites of both the wild-type (wt) allele and the
homologous targeted allele were indicated: exons in orange, YFP
coding sequence in green, LoxP_Neo_LoxP cassette in purple, and
sizes of NcoI restriction fragments in red. Untargeted genomic
DNA from IB10 ES cells (lane 1) and chromosomal DNA of tails
from 129 mouse strain (lane 2) were loaded as control. Twelve
homologous recombinant ES cell lines (e.g., in lane 3) out of 128
analyzed G418-resistant transformants were obtained (9% target-
ing frequency). (B) Immunoblot of total cellular protein extracts
from three targeted ES clones (lanes 2–4) and a nontargeted ES
clone (lane 1) as negative control was performed using an antibody
against the HA tag (3F10, Roche). (C) Scheme of the amplification
strategy to identify wt, heterozygous, and homozygous animals.
Two sets of primers: set A (Iforward [If] + Ireverse [Ir]) and set B
(Iforward [If] + IIreverse [IIr]) amplify the untargeted allele (set A) or
the targeted allele (set A and B). The size of the fragment amplified
by primer set A discriminates the untargeted allele (Xpb
+ allele:
470 bp amplification, upper scheme) from the targeted allele
containing the neomycin-resistant marker (Xpb
y2Neo allele:
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allele without the NeoMarker (Xpb
y allele: 1,180 bp amplification,
lower scheme). (D) Amplification of genomic DNA from
untargeted Xpb
+/+ (lane 1), heterozygous Xpb
y/+ (lane 2), and
homozygous Xpb
y/y mice (lane 3) after recombining out the
LoxP_Neo_LoxP cassette. Lane M: marker. (E) Amplification of
genomic DNA from Xpb
+/+ (lane 1and 2), Xpb
y2Neo/+ (lane 3 and
4), and Xpb
y/+ mice (lane 5 and 6). Lane M: marker.
Found at: doi:10.1371/journal.pbio.1000220.s001 (0.53 MB TIF)
Figure S2 Characterization of cell expressing fluores-
cently tagged TFIIH (XPB-YFP). (A) Comparative immuno-
fluorescence of a mixed population of dermal fibroblasts isolated
from an untargeted mouse (Xpb
+/+, HA negative) and a targeted
mouse (Xpb
y/y, HA positive), stained with anti-p62 (red, left) or
anti-HA (green, right), which recognizes the XPB-YFP-His6HA
protein. Bar: 10 mm. (B) DNA repair or unscheduled DNA
synthesis (UDS); expressed as percentage of wild-type (wt) UDS
(NER-proficient cells assayed in parallel) of dermal fibroblasts
isolated from Xpb
+/+ mice (wt, green), Xpb
y/y mice (red), and Xpb
y/y
mice crossed with Xpc
2/2 (NER-deficient) mice (blue). UDS in
Xpb
+/+ was set at 100%. (C) Cultured cells derived from the Xpb
y/y
mouse model. The YFP signal and transmission image were merged
from a primary cultures of dermal fibroblasts (left panel) and
keratinocytes (right panel). Notethe uniform expression ofTFIIH in
both cell types. Bar: 20 mm.
Found at: doi:10.1371/journal.pbio.1000220.s002 (1.55 MB
DOC)
Figure S3 TFIIH expression and mobility in neurons. (A)
Image of an organotypic tissue slice of cortex brain from Xpb
y/y.
Bar: 50 mm. (B) Prolonged time-lapse imaging of a cortex neuron
after strip-FRAP. Time scale is expressed in minutes.
Found at: doi:10.1371/journal.pbio.1000220.s003 (3.17 MB
DOC)
Figure S4 Strip-FRAP graphs used to calculate TFIIH
bound fractions indicated in Figure 2C. The dotted square
indicates the approximate time frame used to calculate the
immobile fractions. Mean SEM is the average standard error of
the mean calculated over the entire time range of each FRAP
curve.
Found at: doi:10.1371/journal.pbio.1000220.s004 (0.25 MB TIF)
Figure S5 Mobility of TFIIH and free-GFP in neurons
from the cerebellum. (A) TFIIH mobility in Purkinje cells and
granular neurons in cerebellar organotypic slices. Left upper
panel: immunohistochemistry of a cerebellum paraffin-embedded
section stained with an HA antibody (brown). Left bottom panel:
image of DAPI-stained Purkinje cell and a granular neuron, bar:
10 mm. Right panel: FRAP curve of Purkinje cells (red) and
granular neurons (blue), showing the same TFIIH in these two
different neuron types having different TFIIH concentrations and
chromatin make-ups. (B) Mobility of free GFP in granular neurons
(GN) of the cerebellum from mice that ubiquitously express
nontagged GFP. Left panel: image of GFP-expressing GN, the
dotted circle indicates the nuclear contour, bar: 5 mm. Right
panel: FRAP curve of free GFP (red), indicating that nonfused
GFP is freely mobile in GN.
Found at: doi:10.1371/journal.pbio.1000220.s005 (1.01 MB TIF)
Figure S6 Strip-FRAP graphs used to calculate TFIIH
bound fractions indicated in Figure 3A, section DNA
repair. In blue is TFIIH mobility from cortex neurons of
XPBYFP mice and in red, TFIIH mobility from cortex neurons of
XPBYFP mice crossed into the XPC background. The dotted
square indicates the approximate time frame used to calculate the
immobile fractions. Mean SEM is the average standard error of
the mean calculated over the entire time range of each FRAP
curve.
Found at: doi:10.1371/journal.pbio.1000220.s006 (0.19 MB TIF)
Figure S7 Strip-FRAP graphs used to calculate TFIIH
bound fractions indicated in Figure 3A, section Pol 2
transcription. The dotted square indicates the approximate
time frame used to calculate the immobile fractions. Mean SEM is
the average standard error of the mean calculated over the entire
time range of each FRAP curve.
Found at: doi:10.1371/journal.pbio.1000220.s007 (0.26 MB TIF)
Figure S8 a-Amanitin transcription inhibition. (A) Con-
focal imaging of chondrocytes isolated from Xpb
y/y mice, untreated
(left panel) and (B) treated (right panel) with a-amanitin.
Transcription activity has been measured by incorporating BrU
into nascent m-RNA. Anti-BrU (red), YFP (green), and Dapi
(Blue).
Found at: doi:10.1371/journal.pbio.1000220.s008 (1.60 MB
DOC)
Figure S9 RNAP1 and RNAP2 transcription in neurons.
(A) Image of a cortex neuron within organotypic slice in
transmitted light (TL) (left panel) and fluorescent light (middle
panel). Bar: 10 mm. Left panel: image shows a cortex neuron
within an organotypic brain slice 10 min after bleaching part of
the nucleolus. (B) Semiquantitative reverse transcriptase (RT)-
PCR of pre-rRNA extracted from organotypic cortex slices and
cultured chondrocytes (left panel) and Hela cells (right panel),
incubated at different temperatures and treated with actinomycin
D. (C) Nuclear extract from the brain was immunoprecipitated
with HA-antibodies and subjected to Western blot analysis with
the indicated antibodies. The input lanes represent Immunopre-
cipitation fraction (IP), cleared chromatin (CC) cross-linked extract
before IP, supernatant (S) of cross-linked extract after IP. (D) Bar
graphs representing the quantification of a semiquantitative PCR
on 200 ng of genomic DNA (gDNA) and 200 ng of HA-
precipitated chromatin from cortex slice incubated at 37uC and
4uC. Promoter sequence from Pol1 gene (2119/+7) and
untranscribed region adjacent to the Pol1 gene (Chr 6:
71937600–71938000). The y-axis represents the percentage of
amplified sequences from the HA-precipitated chromatin versus
amplified sequences from gDNA, set to 100%. Error bars have
been calculated for three biological replicates.
Found at: doi:10.1371/journal.pbio.1000220.s009 (0.94 MB
DOC)
Figure S10 Strip-FRAP graphs used to calculate TFIIH
bound fractions indicated in Figure 3A, section Pol 1
transcription. The dotted square indicates the approximate
time frame used to calculate the immobile fractions. Mean SEM is
the average standard error of the mean calculated over the entire
time range of each FRAP curve.
Found at: doi:10.1371/journal.pbio.1000220.s010 (0.23 MB TIF)
Figure S11 Strip-FRAP graphs used to calculate TFIIH
bound fractions indicated in Figure 4A. The dotted square
indicates the approximate time frame used to calculate the
immobile fractions. Mean SEM is the average standard error of
the mean calculated over the entire time range of each FRAP
curve.
Found at: doi:10.1371/journal.pbio.1000220.s011 (0.29 MB TIF)
Figure S12 TFIIH mobility in chondrocytes. (A) Confocal
imaging of chondrocytes isolated from Xpb
y/y mice proliferating
(left panels) and confluent (right panels). Ki67 immunostaining (in
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TFIIH mobility in proliferating (blue) and confluent (red)
chondrocytes.
Found at: doi:10.1371/journal.pbio.1000220.s012 (1.34 MB TIF)
Figure S13 Strip-FRAP graphs used to calculate TFIIH
bound fractions indicated in Figure 4B. The dotted square
indicates the approximate time frame used to calculate the
immobile fractions. Mean SEM is the average standard error of
the mean calculated over the entire time range of each FRAP
curve.
Found at: doi:10.1371/journal.pbio.1000220.s013 (0.27 MB TIF)
Figure S14 Strip-FRAP graphs used to calculate TFIIH
bound fractions indicated in Figure 4C. The dotted square
indicates the approximate time frame used to calculate the
immobile fractions. Mean SEM is the average standard error of
the mean calculated over the entire time range of each FRAP
curve.
Found at: doi:10.1371/journal.pbio.1000220.s014 (0.29 MB TIF)
Figure S15 Strip-FRAP graphs used to calculate TFIIH
bound fractions indicated in Figure 5B. The dotted square
indicates the approximate time frame used to calculate the
immobile fractions. Mean SEM is the average standard error of
the mean calculated over the entire time range of each FRAP
curve.
Found at: doi:10.1371/journal.pbio.1000220.s015 (0.24 MB TIF)
Figure S16 Strip-FRAP graphs used to calculate TFIIH
bound fractions indicated in Figure 5C. The dotted square
indicates the approximate time frame used to calculate the
immobile fractions. Mean SEM is the average standard error of
the mean calculated over the entire time range of each FRAP
curve.
Found at: doi:10.1371/journal.pbio.1000220.s016 (0.29 MB TIF)
Figure S17 Differentiation markers in ES clones. (A)
Transmission light image of a differentiated ES clone stained with
Alizarin Red. Red-stained cells and inclusion are characteristically
highly mineralized (Ca
2+-containing) cells. (B) Transmission light
image of a differentiated ES clone stained with alkaline
phosphatase. Violet-stained cells are osteocytes producing the
enzyme.
Found at: doi:10.1371/journal.pbio.1000220.s017 (5.88 MB TIF)
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